Evidence map›Paper›PMID 38851002›Full record

ReviewRedox biology2024

Interactions between oxidative stress and senescence in cancer: Mechanisms, therapeutic implications, and future perspectives.

Dengxiong Li, Qingxin Yu, Ruicheng Wu, Zhouting Tuo, Jie Wang, Luxia Ye, Fanglin Shao, Premkamon Chaipanichkul, Koo Han Yoo, Wuran Wei and 6 more

Abstract readReview
In one paragraph

Review in Redox biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Dengxiong LiDepartment of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
Qingxin YuDepartment of Pathology, Ningbo Clinical Pathology Diagnosis Center, Ningbo City, Zhejiang Province, 315211, China.
Ruicheng WuDepartment of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
Zhouting TuoDepartment of Urology, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China.
Jie WangDepartment of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
Luxia YeDepartment of Public Research Platform, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China.
Fanglin ShaoDepartment of Rehabilitation, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China.
Premkamon ChaipanichkulDivision of Surgery & Interventional Science, University College London, London, UK.
Koo Han YooDepartment of Urology, Kyung Hee University, South Korea.
Wuran WeiDepartment of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
Uzoamaka Adaobi OkoliDivision of Surgery & Interventional Science, University College London, London, UK; Basic and Translational Cancer Research Group, Department of Pharmacology and Therapeutics, College of Medicine, University of Nigeria, Nsukka, Enugu State, Nigeria.
Shi DengDepartment of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
Mang KeDepartment of Urology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, China. Electronic address: kem@enzemed.com.
William C ChoDepartment of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong SAR, China. Electronic address: williamcscho@gmail.com.
Susan HeaveyDivision of Surgery & Interventional Science, University College London, London, UK. Electronic address: s.heavey@ucl.ac.uk.
Dechao FengDepartment of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China; Division of Surgery & Interventional Science, University College London, London, UK; Department of Urology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, China. Electronic address: dechao.feng@ucl.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecently, numerous studies have reported the interaction between senescence and oxidative stress in cancer. However, there is a lack of a comprehensive understanding of the precise mechanisms involved.

aimTherefore, our review aims to summarize the current findings and elucidate by presenting specific mechanisms that encompass functional pathways, target genes, and related aspects.

methodsPubmed and Web of Science databases were retrieved to search studies about the interaction between senescence and oxidative stress in cancer. Relevant publications in the reference list of enrolled studies were also checked.

resultsIn carcinogenesis, oxidative stress-induced cellular senescence acts as a barrier against the transformation of stimulated cells into cancer cells. However, the senescence-associated secretory phenotype (SASP) is positively linked to tumorigenesis. In the cancer progression stage, targeting specific genes or pathways that promote oxidative stress-induced cellular senescence can suppress cancer progression. In terms of treatment, many current clinical therapies combine with novel drugs to overcome resistance and reduce side effects by attenuating oxidative stress-induced senescence. Notably, emerging drugs control cancer development by enhancing oxidative stress-induced senescence. These studies highlight the complacted effects of the interplay between oxidative stress and senescence at different cancer stages and among distinct cell populations. Future research should focus on characterizing the roles of distinct senescent cell types in various tumor stages and identifying the specific components of SASP. CONCLUDSION: We've summarized the mechanisms of senescence and oxidative stress in cancer and provided illustrative figures to guide future research in this area.

Indexed as

Cellular SenescenceNeoplasmsOxidative StressAnimalsHumansSenescence-Associated Secretory PhenotypeSignal TransductionAgingCancerOxidative stressSASPSenescence

Identifiers

PMID38851002
PMCPMC11201350

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.